Latest update on prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients
F Sherani, C Boston, N Mba - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Chemotherapy-induced nausea and vomiting (CINV) is a
common cause of acute morbidity that impacts quality of life in children receiving cancer …
common cause of acute morbidity that impacts quality of life in children receiving cancer …
Optimizing antiemetic therapy for children undergoing chemotherapy
M Merrow, N King - Journal of Pediatric Nursing, 2022 - Elsevier
Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of most
chemotherapy agents. Suboptimal management of CINV impacts quality of life, nutrition …
chemotherapy agents. Suboptimal management of CINV impacts quality of life, nutrition …
Pediatric ambulatory anesthesia: an update
J Lerman - Current Opinion in Anesthesiology, 2019 - journals.lww.com
Three criteria determine suitability of adenotonsillectomy surgery on an ambulatory basis:
the child's age, comorbidities and the severity of the obstructive sleep apnea syndrome …
the child's age, comorbidities and the severity of the obstructive sleep apnea syndrome …
Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting
The management of chemotherapy-induced nausea and vomiting (CINV) in children
remains challenging due to differences in the chemotherapy regimens, their relative …
remains challenging due to differences in the chemotherapy regimens, their relative …
Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis
A Yamaguchi, Y Saito, Y Takekuma… - Supportive Care in …, 2024 - Springer
Purpose Chemotherapy-induced nausea and vomiting (CINV) are common adverse events
in patients undergoing emetogenic chemotherapy. Palonosetron, a second-generation 5 …
in patients undergoing emetogenic chemotherapy. Palonosetron, a second-generation 5 …
中国抗肿瘤治疗相关恶心呕吐预防和治疗指南(2023 版).
张力 - Chinese Journal of Oncology, 2024 - search.ebscohost.com
恶心是以反胃和(或)急需呕吐为特征的状态. 呕吐是胃内容物经口吐出的一种反射动作.根据 Page 1
中华肿瘤杂志2024 年6 月第46 卷第6 期Chin J Oncol, June 2024, Vol. 46, No. 6 vomiting caused …
中华肿瘤杂志2024 年6 月第46 卷第6 期Chin J Oncol, June 2024, Vol. 46, No. 6 vomiting caused …
A scoping review of biological pathways of integrative interventions used to manage chemotherapy-induced nausea and vomiting in children with cancer
D Kamkhoad, Y Cho, SJ Santacroce - Nursing Research, 2022 - journals.lww.com
Background As with pharmacological management approaches, characteristics of
complementary and alternative medicine (CAM) interventions for managing chemotherapy …
complementary and alternative medicine (CAM) interventions for managing chemotherapy …
[HTML][HTML] Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting …
R Bansal, S Agrawal, S Kohli, K Das - Pediatric Hematology Oncology …, 2023 - Elsevier
Background Chemotherapy-induced nausea and vomiting (CINV) is a common and
significant problem in children receiving chemotherapy. While 5-HT3 blockers are commonly …
significant problem in children receiving chemotherapy. While 5-HT3 blockers are commonly …
Cost‐effectiveness analysis of aprepitant‐based anti‐emetic regimen for children receiving highly emetogenic chemotherapy: Individual patient data analysis of a …
Background Aprepitant has been shown to reduce chemotherapy‐induced nausea and
vomiting in children receiving highly emetogenic chemotherapy (HEC). In this study, we …
vomiting in children receiving highly emetogenic chemotherapy (HEC). In this study, we …
Nausées-vomissements induits par les traitements anticancéreux (NVITAC) en onco-hématologie pédiatrique: recommandations 2022 du Comité soins de support de …
S Thouvenin-Doulet, S Mouffak, A Bertrand… - Bulletin du …, 2022 - Elsevier
Résumé Les nausées et les vomissements, induits par les traitements anticancéreux
(NVITAC), demeurent l'un des effets secondaires les plus fréquents et les plus redoutés …
(NVITAC), demeurent l'un des effets secondaires les plus fréquents et les plus redoutés …